azomycin has been researched along with Disease Exacerbation in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 18 (58.06) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Bottazzi, ME; Dean, DA; Hossain, E; Hotez, PJ; Jones, KM; Kane, SS; Kendricks, AL; Leão, AC; Liu, Z; McCall, LI; Pollet, J; Sankaranarayanan, K; Ulrich vonBargen, R; Wheeler, K | 1 |
| Díaz, ML; Echeverría, LE; Eduardo Nieto, J; González, CI; Hernandez, JCM; López-Romero, LA; Morillo, CA; Ochoa, SAG; Rivera, JD; Rojas, LZ; Suárez, EU | 1 |
| Alonso-Padilla, J; Alonso-Vega, C; Cortés-Serra, N; Gascón, J; Losada Galván, I; Pinazo, MJ | 1 |
| Bahia, MT; Caldas, IS; Caldas, S; Diniz, LF; Menezes, APJ; Nascimento, ÁFDSD; Novaes, RD | 1 |
| Egui, A; Lasso, P; López, MC; Pérez-Antón, E; Thomas, MC | 1 |
| Ahmed, M; Ba-Alawi, W; Beltran, H; Berlin, A; Boutros, PC; Bristow, RG; Chen, S; Ci, X; Ellis, L; Fazli, L; Feng, FY; Gleave, M; Guo, H; Haibe-Kains, B; He, HH; Hua, JT; Koritzinsky, M; Li, E; Liang, Y; Lin, D; Mahamud, O; Nguyen, T; Poirier, JT; Puca, L; Rudin, CM; Sheahan, AV; Soares, F; Su, P; Tsao, MS; van der Kwast, T; Vellanki, RN; Vosoughi, A; Wang, Y; Wouters, BG; Xu, J; Xu, X; Xue, H; Zhang, S; Zhang, Y; Zoubeidi, A | 1 |
| Echeverria, LE; Morillo, CA | 1 |
| Asti, L; Bartsch, SM; Bottazzi, ME; Falcón-Lezama, JA; Hotez, PJ; Lee, BY; Meymandi, S; Randall, S; Strych, U | 1 |
| Coura, JR; de Macedo, RC; Ferreira, AG; Junqueira, AC; Pinto, AY; Santos, LC; Valente, SA; Valente, Vda C | 1 |
| Albajar-Viñas, P; Coura, JR; Dias, JC; Diniz, GA; Lana, Md; Machado-Coelho, GL; Machado-de-Assis, GF; Montoya, RA; Torres, RM | 1 |
| Bahary, N; Borad, MJ; Chiorean, EG; Cohn, AL; Del Prete, SA; Dragovich, T; Eng, C; Kroll, S; Rarick, M; Reddy, SG; Rosen, PJ; Ryan, DP; Schelman, WR; Sigal, D; Stephenson, J; Ulrich, B; Uronis, HE | 1 |
| Avezum, A; Bonilla, L; Bonilla, R; Britto, C; Connolly, SJ; Guhl, F; Lazdins, J; Marin-Neto, JA; Mattos, A; Meeks, B; Morillo, CA; Pogue, J; Quiroz, R; Rao-Melacini, P; Rassi, A; Rosas, F; Sosa-Estani, S; Velazquez, E; Villena, E; Yusuf, S | 1 |
| Ciapponi, A; Comandé, D; Cuesta, CB; Hicks, E; Roberts, KN; Sguassero, Y; Sosa-Estani, S | 1 |
| Bierrenbach, AL; Cardoso, CS; Cunha-Neto, E; de Oliveira, LC; Ferreira, AM; Ferreira, JE; Haikal, DS; Oliveira, CD; Reingold, AL; Ribeiro, AL; Sabino, EC | 1 |
| Pays, JF | 1 |
| Marin, JA; Rassi, A | 1 |
| Condon, D; Dhiman, M; Garg, NJ; Guan, Z; Gupta, S; Lui, C; Wen, JJ | 1 |
| Bendell, JC; Borad, MJ; Burris, HA; Chiorean, EG; Infante, JR; Jones, SF; Kroll, S; Lacouture, ME; Langmuir, VK; Lee, H; Lewandowski, K; Molina, JR; Ramanathan, RK; Tibes, R; Weiss, GJ | 1 |
| Bern, C | 1 |
| Ayala, E; Fisa, R; Gállego, M; Gascon, J; Monteagudo, J; Muñoz, J; Pinazo, MJ; Posada, Ede J; Reverter, JC; Tàssies, D | 1 |
| Biagini, G; Gualtieri, F; Longo, D; Marinelli, C; Meletti, S; Nichelli, PF; Pugnaghi, M | 1 |
| Basile, DP; Donohoe, DL; Mattson, DL; Roethe, K | 1 |
| Büchler, MW; Büchler, P; Friess, H; Hines, OJ; Lavey, RS; Reber, HA; Tomlinson, J | 1 |
| Adomat, H; Bowden, M; Dragowska, W; Gleave, M; Koch, CJ; Skov, K; Woo, J; Yapp, DT | 1 |
| Asosingh, K; De Raeve, H; de Ridder, M; Storme, GA; Van Camp, B; Van Riet, I; Vanderkerken, K; Willems, A | 1 |
| Colmenarez-Mendoza, HJ; Dávila-Spinetti, DF; Lobo-Vielma, L | 1 |
| Alvarez, MG; Armenti, A; Bertocchi, G; Lococo, B; Petti, M; Vigliano, C; Viotti, R | 1 |
| Alvarez, MG; Armenti, A; Bertocchi, G; Lococo, B; Petti, M; Postan, M; Vigliano, C; Viotti, R | 1 |
| Del Bigio, MR; Nijjar, SS | 1 |
| Bijnens, AP; Cleutjens, JP; Corvol, P; Daemen, MJ; Gasc, JM; Groeneweg, M; Kisters, N; Sluimer, JC; Sollewijn Gelpke, MD; van den Akker, LH; van Wanroij, JL; Wouters, BG | 1 |
4 review(s) available for azomycin and Disease Exacerbation
| Article | Year |
|---|---|
Dynamics of T Cells Repertoire During Trypanosoma cruzi Infection and its Post-Treatment Modulation.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chagas Disease; Chronic Disease; Disease Progression; Humans; Infectious Disease Transmission, Vertical; Nitroimidazoles; Risk Factors; Trypanosoma cruzi | 2019 |
American Trypanosomiasis (Chagas Disease).
Topics: Animals; Chagas Cardiomyopathy; Chagas Disease; Clinical Trials as Topic; Disease Progression; Disease Vectors; Humans; Nitroimidazoles; Triatominae; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Topics: Adult; Antibodies, Protozoan; Chagas Disease; Child; Chronic Disease; Cohort Studies; Disease Progression; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Hemagglutination Tests; Humans; Nifurtimox; Nitroimidazoles; Parasitemia; Randomized Controlled Trials as Topic; Treatment Failure; Trypanocidal Agents; Trypanosoma cruzi; Xenodiagnosis | 2015 |
Antitrypanosomal therapy for chronic Chagas' disease.
Topics: Adult; Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Electrocardiography; Female; Humans; Life Cycle Stages; Nifurtimox; Nitroimidazoles; Practice Guidelines as Topic; Trypanocidal Agents; Trypanosoma cruzi | 2011 |
4 trial(s) available for azomycin and Disease Exacerbation
| Article | Year |
|---|---|
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Disease-Free Survival; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Nitroimidazoles; Pancreatic Neoplasms; Phosphoramide Mustards; Proportional Hazards Models; Time Factors; Treatment Outcome; United States | 2015 |
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
Topics: Adult; Aged; Cardiovascular Diseases; Chagas Cardiomyopathy; Chronic Disease; Disease Progression; Female; Genotype; Humans; Male; Middle Aged; Nitroimidazoles; Parasite Load; Polymerase Chain Reaction; Proportional Hazards Models; Prospective Studies; Treatment Failure; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Cell Hypoxia; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Models, Biological; Neoplasms; Nitroimidazoles; Phosphoramide Mustards; Prodrugs | 2011 |
Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.
Topics: Adult; Animals; Antibodies, Protozoan; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Prognosis; Sensitivity and Specificity; Trypanocidal Agents; Trypanosoma cruzi | 2006 |
23 other study(ies) available for azomycin and Disease Exacerbation
| Article | Year |
|---|---|
Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease.
Topics: Animals; Chagas Disease; Disease Progression; Heart; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas.
Topics: Acute Disease; Animals; Chagas Disease; Disease Models, Animal; Disease Progression; DNA, Protozoan; Drug Therapy, Combination; Nitroimidazoles; Parasite Load; Parasitemia; Rats; Rats, Wistar; Triazoles; Trypanocidal Agents | 2020 |
Benznidazole for the treatment of Chagas disease.
Topics: Adult; Chagas Disease; Disease Progression; Female; Humans; Infectious Disease Transmission, Vertical; Nitroimidazoles; Pregnancy; Pregnancy Complications, Infectious; Trypanocidal Agents | 2021 |
Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Chronic Disease; Collagen Type III; Disease Models, Animal; Disease Progression; DNA, Protozoan; Dogs; Drug Resistance; Fibrosis; Heart; Myocardium; Nitroimidazoles; Parasite Load; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
ONECUT2 is a driver of neuroendocrine prostate cancer.
Topics: Animals; Carcinogenesis; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Datasets as Topic; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroendocrine Tumors; Nitroimidazoles; Phosphoramide Mustards; Prostate; Prostatic Neoplasms; RNA, Small Interfering; Signal Transduction; Smad3 Protein; Transcription Factors; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients.
Topics: Cardiomyopathies; Chagas Disease; Chronic Disease; Cost-Benefit Analysis; Disease Progression; Humans; Nitroimidazoles; Trypanosoma cruzi; Vaccination; Vaccines | 2019 |
Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Protozoan; Brazil; Chagas Cardiomyopathy; Chagas Disease; Child; Child, Preschool; Disease Progression; Follow-Up Studies; Humans; Immunoglobulin G; Middle Aged; Nitroimidazoles; Topography, Medical; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2013 |
A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention.
Topics: Adolescent; Adult; Case-Control Studies; Chagas Disease; Child; Disease Progression; Female; Humans; Male; Nitroimidazoles; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2013 |
Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile.
Topics: Aged; Biomarkers; Brazil; Chagas Cardiomyopathy; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Heart Failure; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Natriuretic Peptide, Brain; Nitroimidazoles; Peptide Fragments; Population Surveillance; Predictive Value of Tests; Prognosis; Prospective Studies; Quality of Life; Socioeconomic Factors | 2016 |
[The third and new face of Chagas disease].
Topics: Adult; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Humans; Neglected Diseases; Nitroimidazoles; Treatment Failure | 2016 |
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.
Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Clinical Trials as Topic; Disease Progression; Female; Humans; Latin America; Male; Middle Aged; Nitroimidazoles; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2017 |
Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats.
Topics: Analysis of Variance; Animals; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Cyclic N-Oxides; Disease Models, Animal; Disease Progression; Heart Function Tests; Hemodynamics; Lipid Peroxidation; Mitochondria, Heart; Nitroimidazoles; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Trypanosoma cruzi | 2010 |
Hypercoagulability biomarkers in Trypanosoma cruzi -infected patients.
Topics: Adult; Biomarkers; Biomarkers, Pharmacological; Chagas Disease; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Prothrombin; Risk; Thrombin; Thromboembolism; Thrombophilia; Trypanosoma cruzi | 2011 |
Hypoxia markers are expressed in interneurons exposed to recurrent seizures.
Topics: Animals; Anticonvulsants; Biomarkers; Cell Hypoxia; Cerebral Cortex; Convulsants; Diazepam; Disease Progression; Drug Resistance; Epilepsy; HMGB1 Protein; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interneurons; Male; Nerve Tissue Proteins; Neuropeptide Y; Nitroimidazoles; Parvalbumins; Pilocarpine; Rats; Rats, Sprague-Dawley; Recurrence; Seizures; Status Epilepticus | 2013 |
Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage.
Topics: Acute Kidney Injury; Animals; Arginine; Chronic Disease; Disease Progression; Hypoxia; Ischemia; Kidney; Kidney Diseases; Kidney Failure, Chronic; Male; Nephrectomy; Nitroimidazoles; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury; Time Factors | 2003 |
Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model.
Topics: Abdominal Neoplasms; Animals; Cell Hypoxia; Cell Line, Tumor; Disease Progression; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Nitroimidazoles; Oxygen; Pancreatic Neoplasms; Partial Pressure; Staining and Labeling | 2004 |
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.
Topics: Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Flow Cytometry; Hypoxia; Image Cytometry; Male; Mammary Neoplasms, Animal; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Nitroimidazoles; Prognosis; Prostatic Neoplasms; Protein Binding; Time Factors; Tumor Burden | 2004 |
Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.
Topics: Animals; Apoptosis; Bone Marrow Cells; Caspase 3; Caspases; Cell Hypoxia; Disease Progression; Flow Cytometry; Hematopoiesis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leukocyte Common Antigens; Mice; Multiple Myeloma; Neovascularization, Pathologic; Nitroimidazoles | 2005 |
[Mechanisms responsible for myocardial damage progression in chronic Chagas' disease].
Topics: Allopurinol; Antimetabolites; Chagas Cardiomyopathy; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Electrocardiography; Follow-Up Studies; Humans; Nitroimidazoles; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Trypanocidal Agents | 2005 |
[Clinical predictors of chronic chagasic myocarditis progression].
Topics: Adult; Chagas Cardiomyopathy; Disease Progression; Echocardiography; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocarditis; Nitroimidazoles; Prognosis; Proportional Hazards Models; Risk Factors; Time Factors; Trypanocidal Agents | 2005 |
Summaries for patients. Long-term outcomes of treating nonacute Chagas disease with benznidazole.
Topics: Adult; Animals; Antibodies, Protozoan; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroimidazoles; Prognosis; Sensitivity and Specificity; Trypanocidal Agents; Trypanosoma cruzi | 2006 |
Cerebral trypanosomiasis in an incarcerated man.
Topics: Adult; Animals; Biopsy, Needle; Central Nervous System Protozoal Infections; Craniotomy; Disease Progression; Fatal Outcome; Humans; Immunohistochemistry; Male; Manitoba; Nitroimidazoles; Prisoners; Tomography, X-Ray Computed; Trypanosoma; Trypanosomiasis | 2007 |
Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Carotid Stenosis; Cross-Sectional Studies; Disease Progression; Endarterectomy, Carotid; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Immunohistochemistry; Macrophages; Male; Middle Aged; Neovascularization, Pathologic; Nitroimidazoles; Oxidative Stress; RNA, Messenger; Vascular Endothelial Growth Factor A | 2008 |